HERBERT J. CONRAD - 01 Nov 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Director
Signature
/s/ Keith A. Kucinski, attorney-in fact for Herbert J. Conrad
Issuer symbol
MTNB
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
4
Filing time
02 Nov 2021, 16:17:01 UTC
Previous filing
05 Jul 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTNB Stock option (right to buy) Award $0 +90,882 $0.000000 90,882 01 Nov 2021 Common Stock 90,882 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on December 1, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.